All News

Less than 18 months since the policy was put in place, the UK government is reviewing progress on its approach to nanotechnology.

SMEs across Europe are backing to Framework Programme 7 - provided it avoids the funding pitfalls that emerged over the life of its predecessor.

This week the European Investment Fund took the first step in its ambitious new plan to unleash a wave of technology transfer across Europe. In doing so it endorsed a model pioneered in the UK.

On Tuesday the UK became the latest country to jump back on the nuclear energy bandwagon. But 20 years after Chernobyl, how easy is it to turn on the nuclear tap?

India's failure to launch a functional communications satellite using a home-grown rocket is likely to spur even more investment in space programmes.

The European Investment Fund has partnered with UK technology commercialisation company IP Group to form a venture capital fund to invest in university spin-outs.

French researchers have developed a cell therapy that could slash the risk of rejection after bone marrow grafts to under 5 per cent, and are looking for first-round funding.

Nanotechnology looks like generating more paper than profits as yet another policy review gets under way.

For the last three years, the French parliament has been struggling with legislation on copyright and associated rights in information society. It has surfaced in the headlines, portrayed as a fight to force Apple to make its iTunes music downloads playable on competing music boxes. But there's more involved.

A key distinction between physical and intellectual property is that the value of the latter is created as much by sharing it as by owning it. How to share it, between creator and enabler, is a particularly acute issue within the academic environment - as indicated by a recent, noteworthy debate on the subject in Sweden.

Orla Protein Technologies, a spin-out from the University of Newcastle upon Tyne, UK, is looking to raise £3 million in a series A funding round for the next stage of its development.

European food manufacturers are being offered access to a new software tool that takes the trial and error out of devising and developing convenience food recipes,.

TeGenero, the company behind the drug trial fiasco that put six healthy volunteers into intensive care, has announced it is filing for insolvency.

Finland wants to use its six months presiding over the EU to change innovation policy. It picks up the gauntlet at a meeting of competition ministers next week.

As the European Commission ponders the single European patent, the European Patent Office is under attack from national patent offices that want some of its functions.